Whole-brain radiotherapy in patients with brain metastases from melanoma

Macarena I De La Fuente, Kathryn Beal, Richard Carvajal, Thomas J. Kaley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT).

METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence).

RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging.

CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.

Original languageEnglish (US)
Pages (from-to)401-406
Number of pages6
JournalCNS oncology
Volume3
Issue number6
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Melanoma
Radiotherapy
Neoplasm Metastasis
Brain
Radiation
Recurrence
Survival

Keywords

  • brain metastases
  • ipilimumab
  • melanoma
  • overall survival
  • radiographic response
  • WBRT

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Whole-brain radiotherapy in patients with brain metastases from melanoma. / De La Fuente, Macarena I; Beal, Kathryn; Carvajal, Richard; Kaley, Thomas J.

In: CNS oncology, Vol. 3, No. 6, 01.11.2014, p. 401-406.

Research output: Contribution to journalArticle

De La Fuente, Macarena I ; Beal, Kathryn ; Carvajal, Richard ; Kaley, Thomas J. / Whole-brain radiotherapy in patients with brain metastases from melanoma. In: CNS oncology. 2014 ; Vol. 3, No. 6. pp. 401-406.
@article{fea44b4587f84d799245a865a14f6ad8,
title = "Whole-brain radiotherapy in patients with brain metastases from melanoma",
abstract = "AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT).METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence).RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging.CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.",
keywords = "brain metastases, ipilimumab, melanoma, overall survival, radiographic response, WBRT",
author = "{De La Fuente}, {Macarena I} and Kathryn Beal and Richard Carvajal and Kaley, {Thomas J.}",
year = "2014",
month = "11",
day = "1",
doi = "10.2217/cns.14.40",
language = "English (US)",
volume = "3",
pages = "401--406",
journal = "CNS oncology",
issn = "2045-0915",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Whole-brain radiotherapy in patients with brain metastases from melanoma

AU - De La Fuente, Macarena I

AU - Beal, Kathryn

AU - Carvajal, Richard

AU - Kaley, Thomas J.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT).METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence).RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging.CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.

AB - AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT).METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence).RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging.CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.

KW - brain metastases

KW - ipilimumab

KW - melanoma

KW - overall survival

KW - radiographic response

KW - WBRT

UR - http://www.scopus.com/inward/record.url?scp=84938068811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938068811&partnerID=8YFLogxK

U2 - 10.2217/cns.14.40

DO - 10.2217/cns.14.40

M3 - Article

C2 - 25438811

AN - SCOPUS:84938068811

VL - 3

SP - 401

EP - 406

JO - CNS oncology

JF - CNS oncology

SN - 2045-0915

IS - 6

ER -